Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Specialty Generics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Specialty Genericsmarket, defines the market attractiveness level of Specialty Generics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Specialty Generics industry, describes the types of Specialty Generics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Specialty Generics market and the development prospects and opportunities of Specialty Generics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Specialty Generics market in Chapter 13.
By Player:
Mylan NV
Valeant Pharmaceuticals International Inc
Mallinckrodt, Akorn Inc
Sandoz International GmbH
Sun Pharmaceutical Industries Ltd
Endo Pharmaceuticals Inc
Teva Pharmaceuticals USA, Inc
Pfizer Inc
Apotex Corp
By Type:
Injectables
Oral
Others
By End-User:
Oncology
Inflammatory Conditions
Multiple Sclerosis
Hepatitis C
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Specialty Generics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Specialty Generics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Specialty Generics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Specialty Generics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Specialty Generics Market Analysis and Outlook to 2022
-
7.1 Global Specialty Generics Consumption (2017-2022)
-
7.2 United States Specialty Generics Consumption (2017-2022)
-
7.3 Europe Specialty Generics Consumption (2017-2022)
-
7.4 China Specialty Generics Consumption (2017-2022)
-
7.5 Japan Specialty Generics Consumption (2017-2022)
-
7.6 India Specialty Generics Consumption (2017-2022)
-
7.7 South Korea Specialty Generics Consumption (2017-2022)
8 Region and Country-wise Specialty Generics Market Analysis and Outlook to 2028
-
8.1 Global Specialty Generics Consumption Forecast (2022-2028)
-
8.2 United States Specialty Generics Consumption Forecast (2022-2028)
-
8.3 Europe Specialty Generics Consumption Forecast (2022-2028)
-
8.4 China Specialty Generics Consumption Forecast (2022-2028)
-
8.5 Japan Specialty Generics Consumption Forecast (2022-2028)
-
8.6 India Specialty Generics Consumption Forecast (2022-2028)
-
8.7 South Korea Specialty Generics Consumption Forecast (2022-2028)
9 Global Specialty Generics Market Outlook by Types and Applications to 2022
-
9.1 Global Specialty Generics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Injectables Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Oral Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Specialty Generics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Oncology Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Inflammatory Conditions Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Multiple Sclerosis Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Hepatitis C Consumption and Growth Rate (2017-2022)
10 Global Specialty Generics Market Outlook by Types and Applications to 2028
-
10.1 Global Specialty Generics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Injectables Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Specialty Generics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Inflammatory Conditions Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Multiple Sclerosis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Hepatitis C Consumption Forecast and Growth Rate (2022-2028)
11 Global Specialty Generics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Specialty Generics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Specialty Generics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Specialty Generics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Specialty Generics Market Competitive Analysis
-
14.1 Mylan NV
-
14.1.1 Mylan NV Company Details
-
14.1.2 Mylan NV Specialty Generics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Mylan NV Specialty Generics Product and Service
-
14.2 Valeant Pharmaceuticals International Inc
-
14.2.1 Valeant Pharmaceuticals International Inc Company Details
-
14.2.2 Valeant Pharmaceuticals International Inc Specialty Generics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Valeant Pharmaceuticals International Inc Specialty Generics Product and Service
-
14.3 Mallinckrodt, Akorn Inc
-
14.3.1 Mallinckrodt, Akorn Inc Company Details
-
14.3.2 Mallinckrodt, Akorn Inc Specialty Generics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Mallinckrodt, Akorn Inc Specialty Generics Product and Service
-
14.4 Sandoz International GmbH
-
14.4.1 Sandoz International GmbH Company Details
-
14.4.2 Sandoz International GmbH Specialty Generics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Sandoz International GmbH Specialty Generics Product and Service
-
14.5 Sun Pharmaceutical Industries Ltd
-
14.5.1 Sun Pharmaceutical Industries Ltd Company Details
-
14.5.2 Sun Pharmaceutical Industries Ltd Specialty Generics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Sun Pharmaceutical Industries Ltd Specialty Generics Product and Service
-
14.6 Endo Pharmaceuticals Inc
-
14.6.1 Endo Pharmaceuticals Inc Company Details
-
14.6.2 Endo Pharmaceuticals Inc Specialty Generics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Endo Pharmaceuticals Inc Specialty Generics Product and Service
-
14.7 Teva Pharmaceuticals USA, Inc
-
14.7.1 Teva Pharmaceuticals USA, Inc Company Details
-
14.7.2 Teva Pharmaceuticals USA, Inc Specialty Generics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Teva Pharmaceuticals USA, Inc Specialty Generics Product and Service
-
14.8 Pfizer Inc
-
14.8.1 Pfizer Inc Company Details
-
14.8.2 Pfizer Inc Specialty Generics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Pfizer Inc Specialty Generics Product and Service
-
14.9 Apotex Corp
-
14.9.1 Apotex Corp Company Details
-
14.9.2 Apotex Corp Specialty Generics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Apotex Corp Specialty Generics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Specialty Generics
-
Figure Specialty Generics Picture
-
Table Global Specialty Generics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Specialty Generics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Specialty Generics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Specialty Generics Consumption by Country (2017-2022)
-
Figure United States Specialty Generics Consumption and Growth Rate (2017-2022)
-
Table Europe Specialty Generics Consumption and Growth Rate (2017-2022)
-
Figure China Specialty Generics Consumption and Growth Rate (2017-2022)
-
Figure Japan Specialty Generics Consumption and Growth Rate (2017-2022)
-
Figure India Specialty Generics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Specialty Generics Consumption and Growth Rate (2017-2022)
-
Figure Global Specialty Generics Consumption Forecast by Country (2022-2028)
-
Figure United States Specialty Generics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Specialty Generics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Specialty Generics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Specialty Generics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Specialty Generics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Specialty Generics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Injectables Consumption and Growth Rate (2017-2022)
-
Figure Global Oral Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Consumption and Growth Rate (2017-2022)
-
Figure Global Inflammatory Conditions Consumption and Growth Rate (2017-2022)
-
Figure Global Multiple Sclerosis Consumption and Growth Rate (2017-2022)
-
Figure Global Hepatitis C Consumption and Growth Rate (2017-2022)
-
Figure Global Injectables Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Inflammatory Conditions Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Multiple Sclerosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hepatitis C Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Specialty Generics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Specialty Generics Export by Region (Top 5 Countries) (2017-2028)
-
Table Mylan NV (Foundation Year, Company Profile and etc.)
-
Table Mylan NV Specialty Generics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan NV Specialty Generics Product and Service
-
Table Valeant Pharmaceuticals International Inc (Foundation Year, Company Profile and etc.)
-
Table Valeant Pharmaceuticals International Inc Specialty Generics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Valeant Pharmaceuticals International Inc Specialty Generics Product and Service
-
Table Mallinckrodt, Akorn Inc (Foundation Year, Company Profile and etc.)
-
Table Mallinckrodt, Akorn Inc Specialty Generics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mallinckrodt, Akorn Inc Specialty Generics Product and Service
-
Table Sandoz International GmbH (Foundation Year, Company Profile and etc.)
-
Table Sandoz International GmbH Specialty Generics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sandoz International GmbH Specialty Generics Product and Service
-
Table Sun Pharmaceutical Industries Ltd (Foundation Year, Company Profile and etc.)
-
Table Sun Pharmaceutical Industries Ltd Specialty Generics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sun Pharmaceutical Industries Ltd Specialty Generics Product and Service
-
Table Endo Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)
-
Table Endo Pharmaceuticals Inc Specialty Generics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Endo Pharmaceuticals Inc Specialty Generics Product and Service
-
Table Teva Pharmaceuticals USA, Inc (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceuticals USA, Inc Specialty Generics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceuticals USA, Inc Specialty Generics Product and Service
-
Table Pfizer Inc (Foundation Year, Company Profile and etc.)
-
Table Pfizer Inc Specialty Generics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Inc Specialty Generics Product and Service
-
Table Apotex Corp (Foundation Year, Company Profile and etc.)
-
Table Apotex Corp Specialty Generics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Apotex Corp Specialty Generics Product and Service
-
